Literature DB >> 31228799

HIF-1α induced long noncoding RNA FOXD2-AS1 promotes the osteosarcoma through repressing p21.

Zhipeng Ren1, Yongcheng Hu2, Guishi Li3, Yuxiang Kang2, Yancheng Liu2, Hejun Zhao4.   

Abstract

Emerging literature indicates the essential roles of long noncoding RNA (lncRNA) in the osteosarcoma (OS). However, the regulatory function and mechanism of FOXD2-AS1 in the OS is still elusive. In present research, the level of FOXD2-AS1 was significantly up-regulated in the OS tissue and cell lines compared to corresponding controls. The aberrant high-expression of FOXD2-AS1 indicated the poor clinical prognosis of OS patients. Transcription factor HIF-1α could bind with the promoter region of FOXD2-AS1 to activate the transcription in OS cells. Functionally, the knockdown of FOXD2-AS1 could repress the malignant biological properties of OS cells in vitro and vivo, including proliferation, invasion, apoptosis and tumor growth. Mechanistically, FOXD2-AS1 inhibited the expression of p21 via interacting with EZH2 to silence p21 gene expression. Overall, we conclude that FOXD2-AS1, induced by transcription factor HIF-1α, acts as an oncogene in the OS tumorigenesis and FOXD2-AS1 interacts with EZH2 to silence p21 protein. This finding could provide a novel insight and potential therapeutic target for the OS.
Copyright © 2019 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  EZH2; FOXD2-AS1; HIF-1α; Osteosarcoma; p21

Year:  2019        PMID: 31228799     DOI: 10.1016/j.biopha.2019.109104

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  11 in total

Review 1.  Hypoxia-inducible factors: master regulators of hypoxic tumor immune escape.

Authors:  Qinghua Wu; Li You; Eugenie Nepovimova; Zbynek Heger; Wenda Wu; Kamil Kuca; Vojtech Adam
Journal:  J Hematol Oncol       Date:  2022-06-03       Impact factor: 23.168

2.  Long non‑coding RNA FOXD2‑AS1 regulates the tumorigenesis and progression of breast cancer via the S100 calcium binding protein A1/Hippo signaling pathway.

Authors:  Pei Huang; Jinhui Xue
Journal:  Int J Mol Med       Date:  2020-08-10       Impact factor: 4.101

3.  The value of lncRNAs as prognostic biomarkers on clinical outcomes in osteosarcoma: a meta-analysis.

Authors:  Wenchao Zhang; Xiaolei Ren; Lin Qi; Chenghao Zhang; Chao Tu; Zhihong Li
Journal:  BMC Cancer       Date:  2021-02-27       Impact factor: 4.430

4.  Curcumol inhibits malignant biological behaviors and TMZ-resistance in glioma cells by inhibiting long noncoding RNA FOXD2-As1-promoted EZH2 activation.

Authors:  Xuyang Lv; Jiangchuan Sun; Linfeng Hu; Ying Qian; Chunlei Fan; Nan Tian
Journal:  Aging (Albany NY)       Date:  2021-11-05       Impact factor: 5.682

5.  Navigating the genomic instability mine field of osteosarcoma to better understand implications of non-coding RNAs.

Authors:  Kaniz Fatema; Zachary Larson; Jared Barrott
Journal:  Biocell       Date:  2022-06-13       Impact factor: 1.110

6.  LINC00174 Facilitates Cell Proliferation, Cell Migration and Tumor Growth of Osteosarcoma via Regulating the TGF-β/SMAD Signaling Pathway and Upregulating SSH2 Expression.

Authors:  Changjun Zheng; Ronghang Li; Shuang Zheng; Hongjuan Fang; Meng Xu; Lei Zhong
Journal:  Front Mol Biosci       Date:  2021-06-17

Review 7.  Long noncoding RNAs in osteosarcoma via various signaling pathways.

Authors:  Jinming Han; Xiaohan Shen
Journal:  J Clin Lab Anal       Date:  2020-04-06       Impact factor: 2.352

8.  Circular RNA circ-MAT2B facilitates glycolysis and growth of gastric cancer through regulating the miR-515-5p/HIF-1α axis.

Authors:  Jia Liu; Haiying Liu; Qingshan Zeng; Pei Xu; Mingxing Liu; Ning Yang
Journal:  Cancer Cell Int       Date:  2020-05-16       Impact factor: 5.722

Review 9.  The role of FOXD2-AS1 in cancer: a comprehensive study based on data mining and published articles.

Authors:  Yongping Zhang; Chaojie Liang; Yu Zhang; Zhinmin Wang; Ruihuan Li; Zhigang Wei; Jiansheng Guo
Journal:  Biosci Rep       Date:  2020-11-27       Impact factor: 3.840

Review 10.  Osteosarcoma and Metastasis.

Authors:  Gaohong Sheng; Yuan Gao; Yong Yang; Hua Wu
Journal:  Front Oncol       Date:  2021-12-10       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.